Comparing two versions of online Cognitive Behavioural Therapy (CBT) for panic and anxiety in adults: A randomised controlled trial

Not Applicable

Completed

• Conditions: Panic Disorder; Agoraphobia; Mental Health - Anxiety

• Registration Number: ACTRN12618001500246
• Lead Sponsor: niversity of New South Wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-06
• Study Completion: 2020-03-25
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Self-identified as experiencing panic and/or anxiety.
- Meet DSM-5 criteria for panic (with or without comorbid agoraphobia) as assessed by ADIS-5 for DSM-5.
- At least 18 years of age
- Live in Australia
- Fluent in English
- Have access to a computer that is connected to the internet
- Currently under the care of a General Practitioner (have seen GP in last 3 months for any reason; able to provide contact details for GP so a letter can be sent informing GP that patient is enrolled in the study).
- If taking medication, must have been taking the same dose for at least 8 weeks and not intend to change that dose during the course of the program.
- Prepared to provide name, phone number, and address.
- Willing to provide informed consent.

Exclusion Criteria

- Does not meet criteria for panic disorder
- Self-reported diagnosis of schizophrenia, bipolar disorder or current psychotic symptoms
- Regularly using illicit drugs or regularly consuming more than three standard drinks per day (substance dependence)
- Taking benzodiazepines on a daily basis
- Severe depressive symptoms (score of 23 or above on the PHQ-9)
- Current suicidal ideation (defined as responding 3 to the PHQ-9 question 9 item that assesses the frequency of suicidal ideation, and/or responding greater than 1 on the BDI-II suicide item)
-Those scoring 1 or 2 on the Patient Health Questionnaire-9 Item (PHQ-9) item 9 will require a risk assessment with a study clinician before being admitted into the study.
- Changed medication dosage (including starting new medication) within the past 8 weeks.
- Currently participating in Cognitive Behavioural Therapy.
- Do not complete the online screening questionnaire or unwilling to provide demographic details

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in panic symptoms, according to the mean scores on the Panic Disorder Severity Scale - Self-report (PDSS-SR). [Baseline, mid-treatment (before Lesson 4), one week post-treatment (week 9), 3-month post-treatment (week 20), and 6-month post-treatment (week 32). Primary time-point is post-treatment.];Changes in agoraphobia symptoms, according to mean scores on the Mobility Inventory - Alone subscale (MI). [Baseline, mid-treatment (before Lesson 4), one week post-treatment (week 9), 3-month post-treatment (week 20), and 6-month post-treatment (week 32). Primary time-point is post-treatment.]